Maat Pharma SA (MAAT)

Currency in EUR
4.41
-0.02(-0.45%)
Closed·
MAAT Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
MAAT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4.414.56
52 wk Range
4.409.96
Key Statistics
Prev. Close
4.43
Open
4.45
Day's Range
4.41-4.56
52 wk Range
4.4-9.96
Volume
8.87K
Average Volume (3m)
12.24K
1-Year Change
-53.58%
Book Value / Share
0.74
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MAAT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
17.38
Upside
+293.99%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Maat Pharma SA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Maat Pharma Company Profile

MaaT Pharma SA, a late-stage clinical company, engages in the development of gut microbiome-driven therapies to modulate the immune system and improve cancer survival. Its products pipeline includes MaaT013, that is in pivotal phase 3 clinical trial for the treatment of acute graft versus host diseases with gastrointestinal involvement; MaaT033, which is in phase 2b clinical trial for the improvement of survival in patients with acute myeloid leukemia or blood cancer receiving allogeneic hematopoietic stem cell transplantation; and MaaT03X for the treatment of solid tumors, as well as MaaT034 that optimize immune checkpoint inhibitor treatment. The company was incorporated in 2014 and is headquartered in Lyon, France.

Compare MAAT to Peers and Sector

Metrics to compare
MAAT
Peers
Sector
Relationship
P/E Ratio
−2.5x−1.4x−0.5x
PEG Ratio
0.090.020.00
Price/Book
6.9x1.2x2.6x
Price / LTM Sales
22.1x4.8x3.2x
Upside (Analyst Target)
285.5%171.1%44.6%
Fair Value Upside
Unlock5.6%6.5%Unlock

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 17.38
(+293.99% Upside)

Earnings

Latest Release
May 13, 2025
EPS / Forecast
-- / --
Revenue / Forecast
1.10M / --
EPS Revisions
Last 90 days

MAAT Income Statement

FAQ

What Is the Maat Pharma (MAAT) Stock Price Today?

The Maat Pharma stock price today is 4.41.

What Stock Exchange Does Maat Pharma Trade On?

Maat Pharma is listed and trades on the Paris Stock Exchange stock exchange.

What Is the Stock Symbol for Maat Pharma?

The stock symbol for Maat Pharma is "MAAT."

What Is the Maat Pharma Market Cap?

As of today, Maat Pharma market cap is 71.02M.

What Is Maat Pharma's Earnings Per Share (TTM)?

The Maat Pharma EPS (TTM) is -2.21.

When Is the Next Maat Pharma Earnings Date?

Maat Pharma will release its next earnings report on 15 Sept 2025.

From a Technical Analysis Perspective, Is MAAT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Maat Pharma Stock Split?

Maat Pharma has split 0 times.

How Many Employees Does Maat Pharma Have?

Maat Pharma has 63 employees.

What is the current trading status of Maat Pharma (MAAT)?

As of 19 Jul 2025, Maat Pharma (MAAT) is trading at a price of 4.41, with a previous close of 4.43. The stock has fluctuated within a day range of 4.41 to 4.56, while its 52-week range spans from 4.40 to 9.96.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.